Honing Your Cloning

Early attempts to design vehicles for the cloning of foreign DNA produced vectors that were too big, unstable, or unselectable. The tide turned in 1977 with the construction of pBR313, the direct ancestor of the well-known pBR322, which forms the basis of many vectors that are still used extensively today.1 However, the cloning systems introduced in the last year or so seem to be about as related to pBR313 as Ferraris are to little red Radio Flyer wagons. Some of the new protein expression syst

Written byBob Sinclair
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Early attempts to design vehicles for the cloning of foreign DNA produced vectors that were too big, unstable, or unselectable. The tide turned in 1977 with the construction of pBR313, the direct ancestor of the well-known pBR322, which forms the basis of many vectors that are still used extensively today.1 However, the cloning systems introduced in the last year or so seem to be about as related to pBR313 as Ferraris are to little red Radio Flyer wagons. Some of the new protein expression systems allow an easily trackable component to be attached to the protein of interest to facilitate purification or other analyses. Others involve a melange of expression and purification features in a package that allows rapid shuttling of a gene of interest from scenario to scenario.

The first generation of Escherichia coli expression vectors produced an in-frame fusion of the gene of interest and lacZ.2 ß-galactosidase assays ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies